SLI 3025288 / CH0030252883
2’027.15
Pkt
0.16
Pkt
0.01
%
17:30:18
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SLI-Werten
| 16.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 16.01.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 15.01.24 | Roche Neutral | UBS AG | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 15.01.24 | UBS Kaufen | DZ BANK | |
| 15.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 15.01.24 | ABB Sector Perform | RBC Capital Markets | |
| 12.01.24 | Richemont Buy | Deutsche Bank AG | |
| 12.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 12.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 12.01.24 | ams-OSRAM Outperform | Bernstein Research | |
| 11.01.24 | UBS Outperform | RBC Capital Markets | |
| 11.01.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 11.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 10.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
| 10.01.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 10.01.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 10.01.24 | ams-OSRAM Equal Weight | Barclays Capital | |
| 09.01.24 | ABB Hold | Jefferies & Company Inc. | |
| 09.01.24 | Roche Equal Weight | Barclays Capital | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 08.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 05.01.24 | UBS Outperform | RBC Capital Markets | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 04.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 04.01.24 | ABB Market-Perform | Bernstein Research | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Richemont Buy | UBS AG | |
| 03.01.24 | Novartis Buy | Jefferies & Company Inc. |